Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesInfectious DiseaseGlobalHealth PrEP Coverage Policy Update | OpenPay…
    Ask Trek AI about this page
    CurrentglobalhealthPolicy N/A

    Medicare coverage for PrEP (pre-exposure prophylaxis) and associated preventive services

    Customize your policy alerts

    Sign up for all globalhealth policy alerts

    Know when globalhealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medicare coverage of FDA‑approved antiretroviral medications and injectable PrEP for individuals determined by a clinician to be at high risk for HIV; includes counseling, testing, and hepatitis B testing services. Applies to GlobalHealth plan administration of the CMS NCD.

    Policy Summary
    Payerglobalhealth
    PolicyPrEP (pre-exposure prophylaxis) coverage and preventive services for Medicare beneficiaries
    Policy CodePolicy N/A
    Change TypeCMS NCD adoption
    Effective DateN/A
    Next Review DateN/A
    Key ActionPhysician must evaluate and document that the individual is at high risk for acquiring HIV to support coverage.
    SourceLink
    POLICY UPDATE CHANGES

    CMS determined to cover pre-exposure prevention (PrEP) of HIV using FDA‑approved antiretroviral medications, including supply/dispensing and injectable PrEP, as a medically necessary preventive service.

    Coverage includes up to eight counseling visits and up to eight HIV tests every 12 months, plus a single hepatitis B detection test when indicated by FDA or lab regulations.

    8counseling visits covered per 12 months
    8HIV tests covered per 12 months
    1hepatitis B detection test (single)
    Sept 30, 2024CMS determination date

    Coverage Criteria for PrEP and Associated Services

    Initial PrEP coverage and associated services

    Covered when ALL of the following are met

    PrEP coverage criteria

    • Counseling: Up to eight counseling visits every 12 months covering HIV risk assessment (initial or ongoing), risk reduction, and medication adherence; counseling by a doctor or other health professional; individual must be competent and alert at time of counseling.<=8/year
    • HIV testing: Up to eight HIV tests every 12 months.<=8/year
    • Hepatitis B testing: A single test for the detection of hepatitis B covered when indicated as established by the FDA and in accordance with applicable laboratory regulations.
    Policy Summary
    Payerglobalhealth
    PolicyPrEP (pre-exposure prophylaxis) coverage and preventive services for Medicare beneficiaries
    Policy CodePolicy N/A
    Change TypeCMS NCD adoption
    Effective DateN/A
    Next Review DateN/A
    Key ActionPhysician must evaluate and document that the individual is at high risk for acquiring HIV to support coverage.
    SourceLink
    On This Page
    Coverage Criteria for PrEP and Associated ServicesCoding, Quantities, and Testing LimitsProvider Determinations, Documentation, and ProcessDefinitionsBackgroundRevision History and Policy Changes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    single test

    No specific programmatic exclusions are listed in this determination. Coverage is defined to apply to individuals who have been determined by a physician to be at high risk of acquiring HIV; beyond that physician risk determination, the document does not identify additional exclusions.

    The policy does not enumerate explicit "not medically necessary" conditions. Services provided outside the scope described—such as to persons who are not documented by a physician as being at high risk—would not meet the coverage determination and therefore are not covered under this NCD.

    Coding, Quantities, and Testing Limits

    Counseling visits per 12 months — <= 8
    LimitUp to eight counseling visits every 12 months
    Included servicesHIV risk assessment (initial or ongoing), risk reduction, and medication adherence counseling
    ProvidersCounseling by a doctor or other health professional
    Patient conditionIndividual must be competent and alert at the time counseling is offered
    HIV tests per 12 months — <= 8
    LimitUp to eight HIV tests every 12 months
    PurposePeriodic HIV testing as part of preventive PrEP services
    ApplicabilityFor individuals at high risk receiving PrEP per CMS determination

    Provider Determinations, Documentation, and Process

    Prior Authorization

    Physician determination of high risk required

    Coverage is available only when a physician determines the individual is at high risk of acquiring HIV; the determination of high risk is the physician's responsibility based on evaluation of the individual's history. The policy does not specify any prior authorization codes or separate prior authorization process.

    Step Therapy

    No step therapy required

    No step therapy or prior medication-failure requirements are specified in this update; CMS coverage applies without any stated step therapy sequence for PrEP.

    Documentation Required

    Document physician clinical risk assessment

    Maintain documentation of the physician's evaluation and clinical judgment that the individual is at high risk for acquiring HIV to support coverage of PrEP medications and associated services.

    • Retain records of the patient's history and the physician's risk assessment.
    • Include documentation of counseling, HIV testing, and hepatitis B testing when performed per coverage limits.
    Denial Risk

    Denial risk if no physician risk determination documented

    Services may be denied if the individual has not been evaluated and documented by a physician as being at high risk for acquiring HIV; ensure the physician's risk determination is present in the medical record before billing or providing covered PrEP services.

    Definitions

    PrEP — Pre-exposure prevention (PrEP)
    DefinitionPre-exposure prevention (PrEP) — use of FDA‑approved antiretroviral medications to prevent HIV acquisition, including injectable formulations.
    ScopeIncludes supply/dispensing of oral medications and administration of injectable PrEP
    Policy basisCoverage implemented per CMS September 30, 2024 determination as a medically necessary preventive service
    High risk — High risk for acquiring HIV
    DefinitionHigh risk for acquiring HIV — determination to be made by the physician based on evaluation of the individual's history.
    ResponsibilityPhysician is responsible for assessing and documenting high-risk status
    Coverage implicationCoverage applies only to individuals determined to be at high risk by the physician

    Background

    Pre-exposure prophylaxis (PrEP) uses FDA‑approved antiretroviral medications to prevent acquisition of HIV in individuals identified as high risk. Coverage includes supply/dispensing of oral agents and administration of injectable PrEP, and also covers related preventive services: up to 8 counseling visits every 12 months (for HIV risk assessment, risk reduction, and medication adherence), up to 8 HIV tests every 12 months, and a single hepatitis B detection test when indicated by the FDA and applicable laboratory regulations.

    Revision History and Policy Changes

    2024-09-30CMS determination implementedLatest

    CMS determined on September 30, 2024 to cover HIV pre-exposure prophylaxis (PrEP) using FDA‑approved antiretroviral medications, including supply/dispensing and injectable PrEP, as a medically necessary preventive service for individuals at high risk; coverage was implemented into plan policy.